What a Clearance Screening Actually Is and Why It Comes Before Treatment

What a Clearance Screening Actually Is

A clearance screening is the documented clinical evaluation that establishes a treatment is appropriate for a specific patient before that treatment is delivered. The requirement comes from the standard, used across most states in some form, that a prescription or a prescription-adjacent treatment cannot be issued without a physician — or an appropriately supervised provider — actually evaluating the patient in good faith, rather than treating on request without clinical review.

For a med spa, this screening is the gate that sits in front of nearly every service that carries real risk: GLP-1 and weight-management prescribing, injectables, hormone therapy, prescription skincare. It is the point where a real clinical decision gets made — this patient is or is not an appropriate candidate for this treatment, given their history, their current medications, and any contraindications — before anyone picks up a syringe or writes a script.

What the Screening Has to Establish

• Relevant medical history: conditions, allergies, and prior treatments that could affect whether this treatment is appropriate.
• Current medications: checked for interactions or contraindications with the treatment being considered.
• Clinical appropriateness: a documented judgment that this specific patient is a reasonable candidate for this specific treatment.
• The provider's identity and credentials: a clear record of who performed the screening and under what authority — their own license, or a delegation from a supervising physician.
• The outcome and its validity period: approved, approved with conditions, or declined — and how long that clearance remains valid before the patient needs to be re-evaluated.

In-Person vs. Telehealth

Whether a clearance screening can be performed by telehealth, and under what conditions, depends on the state and often on the specific service. Some states permit a broad range of services to be cleared through synchronous video, some require in-person evaluation for higher-risk categories, and some allow asynchronous or store-and-forward review only where the state has clearly authorized it for that specific service. Building a single screening process and applying it uniformly across every state a clinic operates in is one of the more common ways this requirement gets mishandled — a modality that is compliant in one state can fall short of what another requires.

Regardless of modality, the standard that matters is the same: the screening has to be a real clinical evaluation, not a formality that happens after the decision to treat has effectively already been made.

What Skipping or Rushing It Actually Risks

A missing or inadequate clearance screening is one of the most direct exposures a med spa can have, because it sits at the exact point regulators, insurers, and plaintiff's attorneys look first when something goes wrong. A patient with an undisclosed contraindication who was never properly screened, a prescription issued without an adequate evaluation, a chart with no documented clinical reasoning behind an approval — these are not abstract compliance gaps. They are the specific findings that turn an adverse event into a board complaint or a lawsuit.

The screening requirement is also one of the easiest things to let quietly erode under volume pressure. A clinic that started with genuine five-to-ten-minute evaluations can drift, as patient volume grows, toward a rubber-stamp process that technically produces a signed form but does not reflect real clinical judgment. That drift is invisible day to day and becomes the central issue the moment anyone actually reviews the chart.

How Often Clearances Need to Be Renewed

A clearance screening does not clear a patient indefinitely. Depending on the service and the state, a clearance is valid for a defined period — often tied to how the treatment works clinically, such as a monthly or quarterly reassessment for an ongoing prescription program, versus a clearance that is specific to a single procedure visit for something like an injectable treatment. Continuing to treat a patient past their clearance window without a documented re-evaluation is functionally the same gap as never having screened a patient in the first place, even though the initial screening was done correctly.

This is a common failure point specifically because it happens gradually — a patient who was properly cleared at intake keeps returning for refills or follow-up treatments, and the re-evaluation step quietly stops happening as the relationship becomes routine. Building a system that actually tracks clearance expiration, rather than relying on staff to remember, is a large part of what separates a compliant program from one drifting toward non-compliance without anyone deciding to let that happen.

What Good Documentation Actually Contains

• The specific findings, not just the outcome: a chart that says "approved" with no supporting detail is much weaker than one that documents what was reviewed and why the outcome followed.
• A timestamp and provider signature: establishing exactly when the screening happened and who is accountable for it.
• Any conditions attached to the approval: if the clearance came with a caveat — a lower starting dose, a required follow-up — that condition needs to be documented and tracked, not just noted verbally to the patient.
• A record of the modality used: in-person, synchronous video, or asynchronous review — since this is often exactly the detail a state's rules turn on.

Why Volume Is the Real Test of a Clearance Screening Process

A clearance screening process is easy to run well at low volume, because a single engaged provider can genuinely evaluate a handful of patients a day without cutting any corners. The real test comes as volume grows — ten patients a day becomes thirty, one provider becomes a rotating group covering shifts, and the same evaluation that used to take ten unhurried minutes starts getting compressed to keep pace with the schedule. This is the point where most screening-quality erosion actually happens, and it happens gradually enough that no single day looks like a problem.

The structural fix is not asking providers to work faster or hoping volume levels off — it is building enough qualified provider capacity that screening quality does not have to trade off against patient volume in the first place. A clinic relying on one provider to personally evaluate every patient will eventually be forced to choose between turning patients away and rushing screenings; a clinic with a real bench of providers does not have to make that choice.

What a Real Process Looks Like

A durable clearance screening process has three things: a provider who is actually qualified and authorized to perform the screening for the specific service in question, a modality (in-person or telehealth) that is compliant for that service in that state, and documentation thorough enough to show — months or years later, if it is ever reviewed — that a real clinical evaluation happened and produced a specific, reasoned outcome.

This is the layer of the clinical process MedGrid's medical director and mid-level provider team is built specifically to run at volume without it degrading — a bench of providers rather than a single calendar, so screening quality does not erode as patient volume grows.